177 related articles for article (PubMed ID: 27977318)
1. Nebulized Recombinant Human Tissue Factor Pathway Inhibitor Attenuates Coagulation and Exerts Modest Anti-inflammatory Effects in Rat Models of Lung Injury.
van den Boogaard FE; Hofstra JJ; Brands X; Levi MM; Roelofs JJ; Zaat SA; Van't Veer C; van der Poll T; Schultz MJ
J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):91-99. PubMed ID: 27977318
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and Safety of Local Treatment with Recombinant Human Tissue Factor Pathway Inhibitor in a Rat Model of Streptococcus pneumoniae Pneumonia.
van den Boogaard FE; Hofstra JJ; van 't Veer C; Levi MM; Roelofs JJ; van der Poll T; Schultz MJ
PLoS One; 2015; 10(5):e0127261. PubMed ID: 25992779
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia.
Van Den Boogaard FE; Brands X; Schultz MJ; Levi M; Roelofs JJ; Van 't Veer C; Van Der Poll T
J Thromb Haemost; 2011 Jan; 9(1):122-32. PubMed ID: 21029363
[TBL] [Abstract][Full Text] [Related]
4. Nebulized anticoagulants limit coagulopathy but not inflammation in pseudomonas aeruginosa-induced pneumonia in rats.
Cornet AD; Hofstra JJ; Vlaar AP; van den Boogaard FE; Roelofs JJ; van der Poll T; Levi M; Groeneveld AB; Schultz MJ
Shock; 2011 Oct; 36(4):417-23. PubMed ID: 21897338
[TBL] [Abstract][Full Text] [Related]
5. Nebulized anticoagulants limit pulmonary coagulopathy, but not inflammation, in a model of experimental lung injury.
Hofstra JJ; Vlaar AP; Cornet AD; Dixon B; Roelofs JJ; Choi G; van der Poll T; Levi M; Schultz MJ
J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23(2):105-11. PubMed ID: 20073557
[TBL] [Abstract][Full Text] [Related]
6. Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury.
Chimenti L; Camprubí-Rimblas M; Guillamat-Prats R; Gomez MN; Tijero J; Blanch L; Artigas A
Thromb Haemost; 2017 Nov; 117(11):2125-2134. PubMed ID: 29202212
[No Abstract] [Full Text] [Related]
7. Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation.
Choi G; Vlaar AP; Schouten M; Van't Veer C; van der Poll T; Levi M; Schultz MJ
Eur Respir J; 2007 Sep; 30(3):423-8. PubMed ID: 17537762
[TBL] [Abstract][Full Text] [Related]
8. Nebulized antithrombin limits bacterial outgrowth and lung injury in Streptococcus pneumoniae pneumonia in rats.
Hofstra JJ; Cornet AD; de Rooy BF; Vlaar AP; van der Poll T; Levi M; Zaat SA; Schultz MJ
Crit Care; 2009; 13(5):R145. PubMed ID: 19740417
[TBL] [Abstract][Full Text] [Related]
9. Nebulized fibrinolytic agents improve pulmonary fibrinolysis but not inflammation in rat models of direct and indirect acute lung injury.
Hofstra JJ; Cornet AD; Declerck PJ; Dixon B; Aslami H; Vlaar AP; Roelofs JJ; van der Poll T; Levi M; Schultz MJ
PLoS One; 2013; 8(2):e55262. PubMed ID: 23408962
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa pneumonia in rats.
Choi G; Hofstra JJ; Roelofs JJ; Florquin S; Bresser P; Levi M; van der Poll T; Schultz MJ
Crit Care Med; 2007 May; 35(5):1362-8. PubMed ID: 17414732
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.
de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van Der Poll T
Blood; 2000 Feb; 95(4):1124-9. PubMed ID: 10666180
[TBL] [Abstract][Full Text] [Related]
12. Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response.
Robriquet L; Collet F; Tournoys A; Prangère T; Nevière R; Fourrier F; Guery BP
Respir Res; 2006 Mar; 7(1):41. PubMed ID: 16553944
[TBL] [Abstract][Full Text] [Related]
13. Plasma-derived human antithrombin attenuates ventilator-induced coagulopathy but not inflammation in a Streptococcus pneumoniae pneumonia model in rats.
Aslami H; Haitsma JJ; Hofstra JJ; Florquin S; Dos Santos C; Streutker C; Zhang H; Levi M; Slutsky AS; Schultz MJ
J Thromb Haemost; 2012 Mar; 10(3):399-410. PubMed ID: 22236057
[TBL] [Abstract][Full Text] [Related]
14. Inhaled unfractionated heparin improves abnormalities of alveolar coagulation, fibrinolysis and inflammation in endotoxemia-induced lung injury rats.
Wang ZY; Wu SN; Zhu ZZ; Yang BX; Zhu X
Chin Med J (Engl); 2013 Jan; 126(2):318-24. PubMed ID: 23324284
[TBL] [Abstract][Full Text] [Related]
15. Effects of nebulized antithrombin and heparin on inflammatory and coagulation alterations in an acute lung injury model in rats.
Camprubí-Rimblas M; Tantinyà N; Guillamat-Prats R; Bringué J; Puig F; Gómez MN; Blanch L; Artigas A
J Thromb Haemost; 2020 Mar; 18(3):571-583. PubMed ID: 31755229
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor pathway inhibitor prevents airway obstruction, respiratory failure and death due to sulfur mustard analog inhalation.
Rancourt RC; Veress LA; Ahmad A; Hendry-Hofer TB; Rioux JS; Garlick RB; White CW
Toxicol Appl Pharmacol; 2013 Oct; 272(1):86-95. PubMed ID: 23727623
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia.
de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van der Poll T
J Infect Dis; 2001 Jun; 183(12):1815-8. PubMed ID: 11372037
[TBL] [Abstract][Full Text] [Related]
18. Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation.
Enkhbaatar P; Okajima K; Murakami K; Uchiba M; Okabe H; Okabe K; Yamaguchi Y
Am J Respir Crit Care Med; 2000 Nov; 162(5):1752-9. PubMed ID: 11069808
[TBL] [Abstract][Full Text] [Related]
19. Recombinant tissue factor pathway inhibitor prevents lipopolysaccharide-induced systemic hypotension in rats by inhibiting excessive production of nitric oxide.
Enkhbaatar P; Okajima K; Uchiba M; Isobe H; Okabe H
Thromb Haemost; 2001 Dec; 86(6):1573-7. PubMed ID: 11776329
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary coagulation and fibrinolysis abnormalities that favor fibrin deposition in the lungs of mouse antibody-mediated transfusion-related acute lung injury.
Yu Y; Jiang P; Sun P; Su N; Lin F
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
